Examination of peptide neurotransmitters may lead to new insights in degenerative neurologic illnesses. The goals of this study are (1) to determine neuroanatomic pathways involving somatostatin in the basal ganglia, (2) to measure their relative contribution to the basal ganglia content of somatostatin-like immunoreactivity (SLI) as determined by radioimmunoassay (3) to study interactions between somatostatin and dopamine and its metabolites in the striatum and conversely the effects of dopamine blocking drugs on striatal SLI (4) to determine levels of somatostatin and other peptides in Parkinson's disease and to examine the normal distribution of somatostatin and other peptides within human basal ganglia (5) to measure somatostatin receptors in Huntington's disease and correlate this with the increased levels of SLI we have observed in basal ganglia in this illness. Somatostatin pathways within the basal ganglia will initially be examined by continuing our lesion studies followed by determination of striatal SLI in striatal punches by a specific radioimmunoassay. Specific pathways will be confirmed using fluorescence retrograde tracing combined with somatostatin immunocytochemistry. The interactions of dopamine and its metabolites with somatostatin will be examined using a push-pull cannula model. Dopamine, serotonin and their metabolites will be determined by high pressure liquid chromatography with electrochemical detection. The interactions of SLI with dopamine blocking drugs will be examined by administering these drugs to animals and subsequently measuring both SLI and catecholamines. Levels of SLI, substance P, neurotensin and enkephalin will be determined in both Parkinsonian brains and in detailed dissections of normal human brains. Somatostatin receptores will be analyzed in post-mortem tissue from Huntington's disease using a filtration assay with I125Tyr11 somatostatin as a tracer.

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Unknown (R23)
Project #
Application #
Study Section
Neurology B Subcommittee 1 (NEUB)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Massachusetts General Hospital
United States
Zip Code
Beal, M F; Mazurek, M F; Ellison, D W et al. (1988) Somatostatin and neuropeptide Y concentrations in pathologically graded cases of Huntington's disease. Ann Neurol 23:562-9
Kowall, N W; Beal, M F (1988) Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: normal anatomy and alterations in Alzheimer's disease. Ann Neurol 23:105-14
Beal, M F; Ellison, D W; Mazurek, M F et al. (1988) A detailed examination of substance P in pathologically graded cases of Huntington's disease. J Neurol Sci 84:51-61
Beal, M F; Mazurek, M F; McKee, M A (1987) The regional distribution of somatostatin and neuropeptide Y in control and Alzheimer's disease striatum. Neurosci Lett 79:201-6
Beal, M F; Mazurek, M F; Martin, J B (1987) A comparison of somatostatin and neuropeptide Y distribution in monkey brain. Brain Res 405:213-9
Ellison, D W; Beal, M F; Mazurek, M F et al. (1987) Amino acid neurotransmitter abnormalities in Huntington's disease and the quinolinic acid animal model of Huntington's disease. Brain 110 ( Pt 6):1657-73
Chattha, G K; Beal, M F (1987) Effect of cysteamine on somatostatin and neuropeptide Y in rat striatum and cortical synaptosomes. Brain Res 401:359-64
Kowall, N W; Ferrante, R J; Beal, M F et al. (1987) Neuropeptide Y, somatostatin, and reduced nicotinamide adenine dinucleotide phosphate diaphorase in the human striatum: a combined immunocytochemical and enzyme histochemical study. Neuroscience 20:817-28
Ferrante, R J; Kowall, N W; Beal, M F et al. (1987) Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease. J Neuropathol Exp Neurol 46:12-27
Ellison, D W; Beal, M F; Martin, J B (1987) Phosphoethanolamine and ethanolamine are decreased in Alzheimer's disease and Huntington's disease. Brain Res 417:389-92

Showing the most recent 10 out of 33 publications